UK Markets closed

ProPhase Labs, Inc. (PRPH)


NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.09+0.06 (+2.96%)
At close: 4:00PM EDT
People also watch
MSLIRELVPDEXMNOVPSDV
Full screen
Previous close2.03
Open2.02
Bid1.99 x 600
Ask2.49 x 5000
Day's range2.00 - 2.09
52-week range1.28 - 2.45
Volume24,196
Avg. volume36,239
Market cap35.99M
Beta0.52
PE ratio (TTM)0.84
EPS (TTM)2.5
Earnings date27 Mar 2017 - 31 Mar 2017
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.55
Trade prices are not sourced from all markets
  • Marketwired11 days ago

    ProPhase Labs Repurchases 1,061,980 Shares of Its Common Stock

    ProPhase Labs, Inc. today reported that that on June 12, 2017 it entered into a Stock Purchase Agreement with each of Mark S. Leventhal, a former director of the Company, and certain other persons and ...

  • ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 17, 2017
    Capital Cubelast month

    ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 17, 2017

    Categories: Yahoo FinanceGet free summary analysis ProPhase Labs, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of ProPhase Labs, Inc. – Mannatech, Incorporated, Reliv’ International, Inc., USANA Health Sciences, Inc., Nutraceutical International Corporation, Nature’s Sunshine Products, Inc., XOMA Corporation and Emisphere Technologies, Inc. (MTEX-US, RELV-US, ... Read more (Read more...)

  • Marketwiredlast month

    ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2017

    ProPhase Labs, Inc. today reported its financial results for the three months ended March 31, 2017. As previously announced, effective March 29, 2017 and with the approval of the Company's stockholders, ...